Followers | 0 |
Posts | 200 |
Boards Moderated | 1 |
Alias Born | 10/25/2020 |
Thursday, February 01, 2024 12:52:00 PM
Success in stock price is a product of establishing expectations; a recent example being the promotion of gold sales projections, dividend distributions, continued expansion, continued proving of mineral assets, and a continued raising of this company's standards for disclosure, accreditation, and credibility in order to fit in with larger players in this industry. Management's success will be in meeting or exceeding those established expectations.
Sean, in reference to the Twitter post below, I understand you began with SDRC as a retail investor yourself. On Twitter, you straddle a line between being both a giddy investor but also a CEO. I see these in conflict somewhat. To me, seeing a member of management celebrating or deriving validation from price, before fulfilling the expectations IR has established for the business, sends the message that the product your company is selling is not the gold per se but the growing number of shareholders themselves. You should not be focused on selling liquidity. That all comes later after getting the real job done, which is selling gold - necessarily to the degree that expectations were established.
That being said, as a shareholder, personally, I would be dishonest if I said I wasn't happy to watch the stock price steadily rise as it has over the past few years. I stay invested as I affirm that the company's product is indeed gold. As a thank you to me for the trust I offer you as a continued shareholder, I will accept that you continue improving and growing in line with your established expectations, and most importantly, continue nurturing the integrity of your product.
$SDRC in Review. 3 years ago a friend introduced me to the company and my network began participating in the company. The three Major US indices are the lines at the bottom that have barely shifted. Invest domestic. Invest $SDRC #GOLD #ESG #SILVER pic.twitter.com/2SYgYsNOIE
— Sean-Rae Zalewski (@SeanRaeZalewski) February 1, 2024
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM